A Novel Ex Vivo Model to Investigate the Underlying Mechanisms in Alzheimer's Disease.

about

Modulatory Effects of a Novel Cyclized Peptide in Reducing the Expression of Markers Linked to Alzheimer's Disease.

P2860

Q55367685-F2DFFBB9-1983-4BAD-8313-3F349DB1D22B

P2860

A Novel Ex Vivo Model to Investigate the Underlying Mechanisms in Alzheimer's Disease.

Item

http://www.wikidata.org/entity/Q42369956

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

A Novel Ex Vivo Model to Investigate the Underlying Mechanisms in Alzheimer's Disease.

@en

A Novel Ex Vivo Model to Investigate the Underlying Mechanisms in Alzheimer's Disease.

@nl

type

Item

label

A Novel Ex Vivo Model to Investigate the Underlying Mechanisms in Alzheimer's Disease.

@en

A Novel Ex Vivo Model to Investigate the Underlying Mechanisms in Alzheimer's Disease.

@nl

prefLabel

A Novel Ex Vivo Model to Investigate the Underlying Mechanisms in Alzheimer's Disease.

@en

A Novel Ex Vivo Model to Investigate the Underlying Mechanisms in Alzheimer's Disease.

@nl

P1476

A Novel Ex Vivo Model to Investigate the Underlying Mechanisms in Alzheimer's Disease.

@en

P2093

Antoine-Scott Badin

http://www.w3.org/2001/XMLSchema#string

Emanuele Brai

http://www.w3.org/2001/XMLSchema#string

Skye Stuart

http://www.w3.org/2001/XMLSchema#string

Susan A Greenfield

http://www.w3.org/2001/XMLSchema#string

P2860

beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology

Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's disease

Upregulation of alpha7 Nicotinic Receptors by Acetylcholinesterase C-Terminal Peptides.

The cholinergic system in aging and neuronal degeneration.

Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies.

VSDI: a new era in functional imaging of cortical dynamics.

(II) Physiological profiling of an endogenous peptide in the basal forebrain: Age-related bioactivity and blockade with a novel modulator.

(I) Pharmacological profiling of a novel modulator of the α7 nicotinic receptor: Blockade of a toxic acetylcholinesterase-derived peptide increased in Alzheimer brains.

Early neurone loss in Alzheimer's disease: cortical or subcortical?

The cholinergic lesion of Alzheimer's disease: pivotal factor or side show?

P304

291

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FNCEL.2017.00291

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29033787

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

5627036

http://www.w3.org/2001/XMLSchema#string

A Novel Ex Vivo Model to Investigate the Underlying Mechanisms in Alzheimer's Disease.

about

P2860

P2860

A Novel Ex Vivo Model to Investigate the Underlying Mechanisms in Alzheimer's Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932